SCOTT MCINTYRE: Open Payments
NPI 1528554094 · ANSONIA, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,203 in 90 payments from 14 companies in 2025. Trend: 2023 $1,120 · 2024 $1,910 · 2025 $2,203
Food & beverage: $2,119Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $628 |
| Madrigal Pharmaceuticals | 10 | $370 |
| Janssen Biotech, Inc. | 7 | $243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $186 |
| Ardelyx, Inc. | 12 | $173 |
| Gilead Sciences, Inc. | 3 | $162 |
| QOL Medical, LLC | 3 | $110 |
| Phathom Pharmaceuticals, Inc. | 4 | $94 |
| Intercept Pharmaceuticals, Inc. | 3 | $70 |
| PFIZER INC. | 3 | $60 |
Products named: REZDIFFRA, TREMFYA, ENTYVIO, IBSRELA, SKYRIZI, RINVOQ, Livdelzi, Sucraid.
Industry payments across CT — which companies pay providers there.
